Upexi, Inc. (GRVI) Stock Analysis

Upexi, Inc. (GRVI) Healthcare & Pipeline Overview

Upexi, Inc. (GRVI) operates in the specialty and generic drug manufacturing sector, focusing on cannabidiol (CBD) products. The company develops, produces, and markets raw materials, white label products, and end consumer goods, serving diverse markets such as botanical, beauty, pet care, and functional foods.

What Is the Investment Thesis for GRVI?

Upexi, Inc. presents a speculative investment opportunity within the high-growth CBD market. The company's diverse product offerings across botanical, beauty, pet care, and functional food sectors provide multiple revenue streams. However, the company's negative P/E ratio of -0.57 and a profit margin of -496.9% indicate significant challenges in achieving profitability. A key driver for future growth will be Upexi's ability to scale its operations and improve its cost structure. The company's gross margin of 80.0% suggests potential for profitability if operational efficiencies can be achieved. Investors should closely monitor Upexi's progress in expanding its market share and achieving sustainable profitability in the competitive CBD landscape.

Based on FMP financials and quantitative analysis

GRVI Key Highlights

Market capitalization of $88.9M reflects its small-cap status and potential for volatility.

• Negative P/E ratio of -0.57 indicates the company is currently not profitable.
• Gross margin of 80.0% suggests strong potential for profitability if operational costs are managed effectively.
• Profit margin of -496.9% highlights significant challenges in achieving profitability.
• The company operates an annual CBD industry tradeshow, providing a platform for networking and business development.

Who Are GRVI's Competitors?

GRVI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are GRVI's Key Strengths?

Diverse product offerings across multiple consumer markets.

• Vertically integrated operations.
• Established presence in the CBD industry.
• High gross margin of 80.0%.

What Are GRVI's Weaknesses?

Negative P/E ratio and profit margin.

• Limited brand recognition compared to larger competitors.
• Dependence on the regulatory environment for CBD products.
• Small market capitalization.

What Could Drive GRVI Stock Higher?

Potential regulatory changes in the CBD industry could create new market opportunities or challenges.

• Expansion of product offerings into new consumer markets.
• Increased brand awareness and marketing efforts to drive sales growth.
• Strategic partnerships and acquisitions to expand market reach.

What Are the Key Risks for GRVI?

Financial-distress signal — its Altman Z-Score of -0.29 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Intense competition from established players and new entrants in the CBD market.
• Regulatory uncertainty surrounding CBD products could impact the company's operations.
• Fluctuations in the price of raw materials could affect the company's profitability.
• Negative P/E ratio and profit margin indicate financial instability.

What Are the Growth Opportunities for GRVI?

• Expansion into new geographic markets: Upexi can pursue growth by expanding its distribution network into new geographic markets, both domestically and internationally. The global CBD market is projected to reach $55.79 billion by 2028, presenting significant opportunities for companies with a strong brand and distribution capabilities. Timeline: Within the next 2-3 years.
• Development of innovative CBD products: Upexi can invest in research and development to create innovative CBD products that cater to specific consumer needs and preferences. This could include new formulations, delivery methods, or product categories. The market for novel CBD products is expected to grow as consumers become more knowledgeable about the potential benefits of CBD. Timeline: Ongoing.
• Strategic partnerships and acquisitions: Upexi can pursue strategic partnerships and acquisitions to expand its product portfolio, market reach, and technological capabilities. This could involve partnering with established players in the botanical, beauty, pet care, or functional food sectors. Timeline: Within the next 1-2 years.
• Increased focus on online sales and marketing: Upexi can enhance its online sales and marketing efforts to reach a wider audience and drive revenue growth. This could involve investing in search engine optimization (SEO), social media marketing, and e-commerce platforms. The online CBD market is experiencing rapid growth, providing significant opportunities for companies with a strong online presence. Timeline: Ongoing.
• Capitalizing on the growing pet CBD market: The pet CBD market is a rapidly expanding segment within the broader CBD industry. Upexi can leverage its existing pet care product line to capitalize on this trend by developing and marketing new CBD-infused products specifically for pets. This includes treats, oils, and topical applications designed to address various pet health concerns. Timeline: Within the next year.

What Are GRVI's Competitive Advantages?

• Vertically integrated operations from raw materials to end products.
• Diversified product offerings across multiple consumer markets.
• Proprietary formulations and manufacturing processes.
• Established presence in the CBD industry with brand recognition.

What Does GRVI Do?

Upexi, Inc., originally incorporated in 2018 and headquartered in Henderson, Nevada, operates through its subsidiaries to develop, produce, market, and sell a range of products containing cannabidiol (CBD). The company's business revolves around the industrial hemp plant extract, catering to several consumer markets. These markets include the botanical sector, where CBD is used in various plant-based products; the beauty care sector, incorporating CBD into skincare and cosmetic products; the pet care sector, offering CBD-infused products for animals; and the functional food sector, where CBD is added to edible products for its purported health benefits. Upexi also engages in the raw materials and white label product segments, providing CBD ingredients and ready-to-brand products to other businesses. Furthermore, Upexi operates an annual tradeshow related to the CBD industry in the United States, facilitating networking and business opportunities within the sector. The company's vertically integrated approach, from raw material sourcing to end-consumer product sales, allows it to maintain control over quality and supply chain efficiency. Upexi's focus on diverse consumer markets provides multiple avenues for revenue generation and growth within the expanding CBD industry.

What Products and Services Does GRVI Offer?

• Develops and produces raw materials containing cannabidiol (CBD).
• Creates white label CBD products for other businesses.
• Markets and sells end consumer products containing CBD.
• Serves consumer markets including botanical, beauty care, and pet care.
• Offers functional food products infused with CBD.
• Operates an annual tradeshow related to the CBD industry in the United States.

How Does GRVI Make Money?

• Develops and manufactures CBD-based products.
• Sells products directly to consumers through online and retail channels.
• Provides white-label CBD products to other businesses.
• Generates revenue through tradeshow operations.

What Industry Does GRVI Operate In?

Upexi, Inc. operates within the rapidly evolving CBD industry, which has experienced significant growth due to increasing consumer awareness and acceptance of CBD products. The market is characterized by a fragmented competitive landscape, with numerous companies offering a wide range of CBD-infused products. Upexi's focus on diverse consumer markets, including botanical, beauty, pet care, and functional food sectors, positions it to capitalize on various growth trends within the industry. However, the company faces challenges related to regulatory uncertainty and intense competition from both established players and new entrants.

Who Are GRVI's Key Customers?

• Consumers seeking botanical products containing CBD.
• Customers in the beauty care sector looking for CBD-infused products.
• Pet owners interested in CBD products for their animals.
• Individuals seeking functional food products with CBD.
• Businesses seeking white-label CBD products to brand and sell.

Company Profile

Upexi, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Henderson, US. The company is led by CEO Allan J. Marshall. GRVI has traded publicly since 2021.

How Upexi, Inc. Is Valued

Upexi, Inc. carries a market capitalization of $88.9M, placing it in the micro-cap category. Analyst price targets span from $6.00 to $6.00, with a consensus of $6.00. At the current price of $4.95, that implies approximately 21% upside potential.

Key Financial Metrics

Its free cash flow yield is -26.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.72 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -70.9%, the inverse of the P/E and a quick read on earnings relative to price.

Upexi, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.29 places it in the distress zone, a signal of elevated financial risk.

The most recent 12 insider filings for Upexi, Inc. break down as 7 sales and 5 purchases. On net that is roughly 822K shares disposed (about $765K), a signal worth weighing alongside the fundamentals.

GRVI Financials

GRVI Latest News

No recent news available for GRVI.

Common Questions About GRVI (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources